Literature DB >> 28542692

Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.

Dana M Blumberg1, Carlos Gustavo De Moraes1, Alisa J Prager2, Qi Yu2, Lama Al-Aswad1, George A Cioffi1, Jeffrey M Liebmann1, Donald C Hood3.   

Abstract

Importance: Recent evidence supports the presence of macular damage (within 8° of the central field) to retinal ganglion cells and associated central visual field (VF) defects in glaucoma, even in early stages. Despite this, to our knowledge, the association of 10-2 VF damage with vision-related quality of life (QOL) has not been well studied. Objective: To determine the association between QOL and visual function as measured by 24-2 and 10-2 VFs in patients with primary open-angle glaucoma and to test the hypothesis that patients with vision-related QOL disproportionate to their 24-2 VF status may exhibit 10-2 damage overlooked by the 24-2 test. Design, Setting, and Participants: In this cross-sectional analysis of observational cohort study data taken from a tertiary care specialty practice, 113 patients with glaucoma with the entire range of 24-2 VF damage completed the National Eye Institute Visual Function Questionnaire (NEI VFQ-25). Data were collected from May 2014 to January 2015 and were analyzed from March 2016 to May 2016. Interventions: Standardized binocular 24-2 and 10-2 VF sensitivities were calculated for each patient. Main Outcomes and Measures: Association of binocular 24-2 and 10-2 VF sensitivity with Rasch-calibrated NEI VFQ-25 scores. Detection of outliers was based on Cook distance of the regression of binocular 24-2 and NEI VFQ-25 score. Outlier association with QOL was then assessed using a linear regression model, with binocular 10-2 VF sensitivity as the independent variable.
Results: Of the 113 patients, the mean (SD) age was 70.1 (10.9) years, and 51 (45.1%) were male and 71 (62.8%) were white. The composite NEI VFQ-25 score was associated with both binocular 24-2 (β = 1.95; 95% CI, 0.47-3.43; P = .01) and 10-2 (β = 2.57; 95% CI, 1.12-4.01; P = .001) sensitivities, but the 10-2 VF univariable model showed an almost 2-fold better fit to the data (R2 = 9.2% vs 4.9%). However, the binocular 10-2 sensitivities of 24-2 outliers had the strongest association with the composite NEI VFQ-25 scores (β = 2.78; 95% CI, 0.84-4.72; P = .006.) and the best fit to the data (R2 = 18.2%.). Conclusions and Relevance: The 10-2 VF model showed a stronger association with NEI VFQ-25 score than the 24-2 VF model. Patients with disproportionately low quality of vision relative to patients with 24-2 VF damage may have damage on the central field missed by the 24-2 grid. Future prospective testing, including additional dimensions of quality of life, is indicated.

Entities:  

Mesh:

Year:  2017        PMID: 28542692      PMCID: PMC5710200          DOI: 10.1001/jamaophthalmol.2017.1396

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  30 in total

1.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

2.  Early glaucoma involves both deep local, and shallow widespread, retinal nerve fiber damage of the macular region.

Authors:  Donald C Hood; Anastasia Slobodnick; Ali S Raza; Carlos Gustavo de Moraes; Christopher C Teng; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-03       Impact factor: 4.799

3.  Estimating minimally important differences for two vision-specific quality of life measures.

Authors:  Brenda W Gillespie; David C Musch; Leslie M Niziol; Nancy K Janz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-06       Impact factor: 4.799

4.  The relationship between visual field loss in glaucoma and health-related quality-of-life.

Authors:  A van Gestel; C A B Webers; H J M Beckers; M C J M van Dongen; J L Severens; F Hendrikse; J S A G Schouten
Journal:  Eye (Lond)       Date:  2010-11-05       Impact factor: 3.775

5.  Assessment of the vision-specific quality of life using clustered visual field in glaucoma patients.

Authors:  Hideko Sawada; Takaiko Yoshino; Takeo Fukuchi; Haruki Abe
Journal:  J Glaucoma       Date:  2014-02       Impact factor: 2.503

6.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

7.  Estimating linear cortical magnification in human primary visual cortex via dynamic programming.

Authors:  Anqi Qiu; Benjamin J Rosenau; Adam S Greenberg; Monica K Hurdal; Patrick Barta; Steven Yantis; Michael I Miller
Journal:  Neuroimage       Date:  2006-02-08       Impact factor: 6.556

8.  The Impact of Location of Progressive Visual Field Loss on Longitudinal Changes in Quality of Life of Patients with Glaucoma.

Authors:  Ricardo Y Abe; Alberto Diniz-Filho; Vital P Costa; Carolina P B Gracitelli; Saif Baig; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2015-12-15       Impact factor: 12.079

9.  Evaluating clinical change and visual function concerns in drivers and nondrivers with glaucoma.

Authors:  Nancy K Janz; David C Musch; Brenda W Gillespie; Patricia A Wren; Leslie M Niziol
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

Review 10.  Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.

Authors:  Yih-Chung Tham; Xiang Li; Tien Y Wong; Harry A Quigley; Tin Aung; Ching-Yu Cheng
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

View more
  31 in total

1.  Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss.

Authors:  Aakriti Garg; C Gustavo De Moraes; George A Cioffi; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann
Journal:  Am J Ophthalmol       Date:  2018-01-06       Impact factor: 5.258

2.  Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2018-08-10       Impact factor: 5.258

3.  Association of Macular Visual Field Measurements With Glaucoma Staging Systems.

Authors:  Carlos Gustavo De Moraes; Ashley Sun; Ravivarn Jarukasetphon; Rashmi Rajshekhar; Lynn Shi; Dana M Blumberg; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

4.  Comparing 10-2 and 24-2 Visual Fields for Detecting Progressive Central Visual Loss in Glaucoma Eyes with Early Central Abnormalities.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Christopher A Girkin; Linda M Zangwill
Journal:  Ophthalmol Glaucoma       Date:  2019-01-14

5.  Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life.

Authors:  Alisa J Prager; Donald C Hood; Jeffrey M Liebmann; C Gustavo De Moraes; Lama A Al-Aswad; Qi Yu; George A Cioffi; Dana M Blumberg
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

6.  The Relationship Between Intraocular Pressure and Rates of Central Versus Peripheral Visual Field Progression.

Authors:  Aakriti G Shukla; C Gustavo De Moraes; George A Cioffi; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2020-06       Impact factor: 2.503

7.  Disc Hemorrhages Are Associated With the Presence and Progression of Glaucomatous Central Visual Field Defects.

Authors:  Aakriti G Shukla; Portia E Sirinek; C Gustavo De Moraes; Dana M Blumberg; George A Cioffi; Alon Skaat; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill; Donald C Hood; Jeffrey M Liebmann
Journal:  J Glaucoma       Date:  2020-06       Impact factor: 2.503

8.  Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results.

Authors:  Igor Leleu; Benjamin Penaud; Esther Blumen-Ohana; Thibault Rodallec; Raphaël Adam; Olivier Laplace; Jad Akesbi; Jean-Philippe Nordmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-03       Impact factor: 3.117

9.  Patterns of Daily Physical Activity across the Spectrum of Visual Field Damage in Glaucoma Patients.

Authors:  Jian-Yu E; Jennifer A Schrack; Aleksandra Mihailovic; Amal A Wanigatunga; Sheila K West; David S Friedman; Laura N Gitlin; Tianjing Li; Pradeep Y Ramulu
Journal:  Ophthalmology       Date:  2020-06-29       Impact factor: 12.079

10.  Evaluation of a Region-of-Interest Approach for Detecting Progressive Glaucomatous Macular Damage on Optical Coherence Tomography.

Authors:  Zhichao Wu; Denis S D Weng; Abinaya Thenappan; Robert Ritch; Donald C Hood
Journal:  Transl Vis Sci Technol       Date:  2018-03-29       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.